retatrutide diabetes type 1 Medscape | The investigational triple GLP-1/GIP/glucagon receptor agonist produced significant weight loss and A1c reduction in people Retatrutide Benefits: 24% Weight Loss

Although the exact binding sites remain unclear and have not been directly confirmed by structural analyses, these findings enhance our understanding of how GLP-1-related peptides can selectively modulate TRPV1 without broad systemic effects

For people with insulin resistance, diabetes, or who are struggling with their weight, increasing GLP-1 levels naturally can help curb symptoms and assist with weight loss or management

However, long - term use of these drugs is associated with the occurrence of post - intensive care syndrome (PICS)

How does GLP-1 fit into the Gut-Brain Axis

Neal B, Perkovic V, Mahaffey KW, et al